Ratings Türkiye Is Bankasi Borsa Istanbul

Equities

ISBTR

TRAISBTR91N4

Delayed Borsa Istanbul Other stock markets 05:55:13 2024-07-01 EDT			5-day change	1st Jan Change
805,000 ^TRY	0.00%		+17.73%	+41.23%

05-10	Türkiye Is Bankasi A.S. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
05-10	Transcript : Türkiye Is Bankasi A.S., Q1 2024 Earnings Call, May 10, 2024

Strengths

Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
The earnings growth currently anticipated by analysts for the coming years is particularly strong.
Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
The company appears to be poorly valued given its net asset value.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
Historically, the company has been releasing figures that are above expectations.

Ratings chart - Surperformance

Sector: Banks

	1st Jan change	Capi.	ESG Refinitiv
TÜRKIYE IS BANKASI	+41.23%	14.21B	-
JPMORGAN CHASE & CO.	+18.91%	581B	C+
BANK OF AMERICA CORPORATION	+18.12%	311B	C+
INDUSTRIAL AND COMMERCIAL BANK OF CHINA LIMITED	+21.47%	263B	C+
CHINA CONSTRUCTION BANK CORPORATION	+24.09%	187B	B-
BANK OF CHINA LIMITED	+29.19%	175B	B-
HSBC HOLDINGS PLC	+8.77%	158B	C+
HDFC BANK LIMITED	-0.24%	154B	B-
ROYAL BANK OF CANADA	+8.69%	150B	B-
COMMONWEALTH BANK OF AUSTRALIA	+12.88%	142B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes